As of 2025-07-13, the EV/EBITDA ratio of Global Blood Therapeutics Inc (GBT) is -16.85. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. GBT's latest enterprise value is 4,942.22 mil USD. GBT's TTM EBITDA according to its financial statements is -293.25 mil USD. Dividing these 2 quantities gives us the above GBT EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 12.3x - 13.9x | 13.6x |
| Forward P/E multiples | 18.9x - 36.7x | 27.0x |
| Fair Price | (86.72) - (65.25) | (92.76) |
| Upside | -226.6% - -195.3% | -235.4% |
| Date | EV/EBITDA |